Epitalon
Epitalon (epithalon, AEDG): FDA status after the July 2026 advisory vote, why its evidence comes mostly from one Russian group, and the risks.
Not FDA-approved · Evidence grade C · Reviewed
Not approved by the FDA for human use. Not for human consumption. This page describes Epitalon only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer
- Under FDA review, not approvedSleepAdvisory vote for compounding for insomnia, not approval
- Not approvedAgingNot approved
It is not named on the WADA Prohibited List, but no health authority has approved it for human use, so it falls under class S0 (non-approved substances), banned at all times.
Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.
Epitalon (Epithalon, epithalone, AEDG peptide, Ala-Glu-Asp-Gly). Synthetic tetrapeptide.
CNot FDA-approved. Evidence grade C: limited, early or dated human data.
What is Epitalon?
Epitalon is a synthetic four-amino-acid peptide (alanine, glutamic acid, aspartic acid, glycine). It was designed by Vladimir Khavinson's group in St Petersburg from the makeup of epithalamin, a pineal gland extract; FDA treats the two as different substances. It is promoted for sleep and aging.
Is Epitalon FDA-approved?
Not approved for any use. FDA listed it in September 2023 among bulk substances that may present significant safety risks in compounding and removed it from that category on April 22, 2026, ahead of an advisory review. In July 2026 an FDA advisory committee narrowly voted to recommend it for the list of substances pharmacies may compound, for insomnia, after FDA staff advised against it. The vote is advisory. In October 2026 HHS published a draft policy that lists it among peptides it does not intend to act against when pharmacies compound them under set conditions while FDA decides through rulemaking. That is a decision not to enforce, not approval, and it can be withdrawn.
What does the evidence show for Epitalon?
Most studies come from Khavinson's group and are in cells and animals, including reports that it switches on telomerase. FDA found one human study, of 75 women on night shifts, that measured melatonin markers rather than sleep. FDA concluded there are no clinical data supporting its safety in people.
What are the known risks of Epitalon?
FDA has no safety data for people and says injecting it under the skin may carry a particular risk of immune reactions, made worse by clumping and peptide impurities. Sport: it is not named on the WADA Prohibited List, but no health authority has approved it for human use, so it falls under class S0 (non-approved substances), banned at all times.
How is Epitalon measured?
A powder vial: enter the amount in the vial and the water added, and the calculator shows the syringe units for a prescribed dose. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.
Sources: FDA: epitalon briefing document, July 2026; FDA: advisory committee slides, July 2026 (epitalon); FDA: bulk drug substances that may present significant safety risks; FDA: Pharmacy Compounding Advisory Committee, July 23 and 24, 2026; HHS: peptides covered by the draft enforcement discretion policy (Appendix B). This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.